CUSIP 20454B104COMCMPXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
169 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Tang Capital Management LLC | 16.79M | $90.17M | −21.2K | Reduced |
| 2 | Orbimed Advisors LLC | 15.22M | $81.73M | 0 | Held |
| 3 | Suvretta Capital Management, LLC | 14.18M | $76.16M | +81.2K | Added |
| 4 | Vivo Capital, LLC | 9.55M | $51.26M |
| 0 |
| Held |
| 5 | Blackrock, Inc. | 9.39M | $50.42M | +2.02M | Added |
| 6 | Vanguard Group Inc | 8.05M | $43.22M | +985.6K | Added |
| 7 | Enavate Sciences Gp, LLC | 7.79M | $41.82M | 0 | Held |
| 8 | Bvf Inc/Il | 7.76M | $41.70M | +3.01M | Added |
| 9 | Blackstone Inc. | 6.13M | $32.90M | −3.71M | Reduced |
| 10 | State Street Corp | 4.89M | $26.26M | +1.78M | Added |
See every fund holding Compass Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders